Treating 'bad' cholesterol has inconsistent health effects


An analysis of 35 clinical trials found that treatment to reduce LDL cholesterol did not lower the risk of death in over three-quarters of the trials, neither did it lower the risk of heart disease in nearly half of the trials. — TNS

Setting targets for “bad” (low density lipoprotein, LDL) cholesterol levels to ward off heart disease and death in those at risk might seem intuitive.

But decades of research have failed to show any consistent benefit for this approach, reveals an analysis of the available data, published online in the BMJ Evidence Based Medicine journal.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
High cholesterol , heart disease , death , drugs

Next In Health

Faking symptoms to get antibiotics
Premature babies: Their fight to survive�
Diabetic retinopathy: When diabetes steals your sight
Plant proteins can help boost testosterone
How industry players influence government regulators�
When your brain won't let you fall sleep
Dispensing drugs to the disabled
One in four teens not getting enough physical activity
For babies, it's back to sleep, tummy to play�
Circadian depression:�When body clock disruptions affect the mind

Air Pollutant Index

Note: API is calculated based on 24hr running average of the most dominant parameter.

Highest API Readings

    Select State and Location to view the latest API reading

    Others Also Read